Arguments about Sanofi’s Menactra clinical trials for children

Since Sanofi-Pasteur’s ‘Menactra,’ a competing product of the GSK’s top meningococcal meningitis vaccine in Korea, ‘Menveo,’ has been conducted for clinical trials to extend indications in regards to the age group, a rumor said the company is trying to extend the range of indications(age) for Menactra.

Menveo, a tetravalent meningitis vaccine that was first adopted in Korea in 2012, was transf...